Regulus Therapeutics | RGLS - Loan Capital


Regulus Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in June of 2024.



Loan Capital Change Date
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Gilead Sciences USD 22.13B 6M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Grifols EUR 9.95B 722.93M Dec/2025
Immunic USD 0 0 Jun/2024
Incyte USD 30.2M 5.17M Dec/2025
Intrexon USD 0 198.67M Jun/2024
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Lexicon Pharmaceuticals USD 49.41M 7.1M Dec/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
Merck USD 39.97B 6B Sep/2025
Omeros USD 403.72M 27.2M Jun/2024
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 15.72B 150.06M Dec/2025
Takeda JPY 4.27T 81.29B Dec/2025